ATE393780T1 - Reinigungsverfahren zur grossmassstabigen produktion von gc-globulin, damit erhaltenes produkt und dessen verwendung in medizin - Google Patents

Reinigungsverfahren zur grossmassstabigen produktion von gc-globulin, damit erhaltenes produkt und dessen verwendung in medizin

Info

Publication number
ATE393780T1
ATE393780T1 AT02754557T AT02754557T ATE393780T1 AT E393780 T1 ATE393780 T1 AT E393780T1 AT 02754557 T AT02754557 T AT 02754557T AT 02754557 T AT02754557 T AT 02754557T AT E393780 T1 ATE393780 T1 AT E393780T1
Authority
AT
Austria
Prior art keywords
globulin
medicine
scale production
purification process
product
Prior art date
Application number
AT02754557T
Other languages
German (de)
English (en)
Inventor
Charlotte Svaerke Jorgensen
Inga Laursen
Gunnar Houen
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Application granted granted Critical
Publication of ATE393780T1 publication Critical patent/ATE393780T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
AT02754557T 2001-08-14 2002-08-12 Reinigungsverfahren zur grossmassstabigen produktion von gc-globulin, damit erhaltenes produkt und dessen verwendung in medizin ATE393780T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200101217 2001-08-14

Publications (1)

Publication Number Publication Date
ATE393780T1 true ATE393780T1 (de) 2008-05-15

Family

ID=8160667

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02754557T ATE393780T1 (de) 2001-08-14 2002-08-12 Reinigungsverfahren zur grossmassstabigen produktion von gc-globulin, damit erhaltenes produkt und dessen verwendung in medizin

Country Status (9)

Country Link
EP (1) EP1419177B1 (enExample)
JP (1) JP2005508892A (enExample)
AT (1) ATE393780T1 (enExample)
AU (1) AU2002321012B2 (enExample)
CA (1) CA2456843A1 (enExample)
DE (1) DE60226327T2 (enExample)
DK (1) DK1419177T3 (enExample)
ES (1) ES2305272T3 (enExample)
WO (1) WO2003016348A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101005859B (zh) * 2004-06-29 2012-08-15 利莱恩斯生命科学有限公司 灭病毒生物液体的制备方法
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
US8129139B2 (en) * 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
NZ603616A (en) * 2010-05-18 2015-02-27 Abbvie Inc Apparatus and process of purification of proteins
WO2012029954A1 (ja) 2010-09-03 2012-03-08 国立大学法人徳島大学 新規Ｇｃグロブリンガラクトース脱糖体の製造方法
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
US10322147B2 (en) 2013-12-13 2019-06-18 Saisei Pharma Co., Ltd. Enzyme-treated bovine colostrum, preparation method thereof, composition, and foods and beverages
WO2015158776A1 (en) * 2014-04-15 2015-10-22 Boehringer Ingelheim International Gmbh Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product
US11464835B2 (en) * 2015-06-01 2022-10-11 Saisei Pharma Co., Ltd. Enzyme-treated milk product, preparation method thereof, composition, and products

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177002A (en) * 1989-11-20 1993-01-05 Nobuto Yamamoto In vitro enzymatic conversion of glycosylated human vitamin D binding protein to a potent macrophage activating factor
ATE171625T1 (de) * 1990-04-11 1998-10-15 Brigham & Womens Hospital Therapeutische verwendung von actin-bindenden verbindungen
US6268478B1 (en) * 1996-02-12 2001-07-31 Cedars-Sinai Medical Center Intracellular vitamin D binding protein

Also Published As

Publication number Publication date
DE60226327D1 (de) 2008-06-12
DK1419177T3 (da) 2008-08-25
AU2002321012B2 (en) 2008-07-24
WO2003016348A2 (en) 2003-02-27
WO2003016348A3 (en) 2004-03-04
EP1419177A2 (en) 2004-05-19
JP2005508892A (ja) 2005-04-07
DE60226327T2 (de) 2009-07-09
EP1419177B1 (en) 2008-04-30
CA2456843A1 (en) 2003-02-27
ES2305272T3 (es) 2008-11-01

Similar Documents

Publication Publication Date Title
US10005823B2 (en) Peptides having effects on promoting wound healing, collagen production, angiogenesis, activation of immunocytes and applications thereof
EP2270511A3 (en) Method of therapy
ATE130365T1 (de) Bakterien transformiert mit expressionsplasmiden, die für den menschlichen neurothrophen wimper faktor (h-cntf) kodieren, ihre verwendung in der herstellung von h-cntf, antikörper gegen h-cntf und die anwendung von h-cntf in medizischer behandlung.
Olaniyan et al. Raw cucumber (Cucumis sativus) fruit juice as possible first-aid antidote in drug-induced toxicity
ATE393780T1 (de) Reinigungsverfahren zur grossmassstabigen produktion von gc-globulin, damit erhaltenes produkt und dessen verwendung in medizin
RU95110699A (ru) Устройство для обработки крови, озоновый генератор для производства озона, устройство для контакта газа и жидкости, способ инактивации вируса иммунодефицита человека в белковом материале
ATE209684T1 (de) Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung
Shogenova et al. Hydrogen inhalation in rehabilitation program of the medical staff recovered from COVID-19
YU73301A (sh) eNOS MUTACIJE,NJIHOVA UPOTREBA ZA PRIPREMU LEKA ZA GENSKU TERAPIJU I POSTUPCI TERAPEUTSKOG SKRININGA
FI953565A7 (fi) Uusi antikoagulanttikofaktoriaktiivisuus
Chen et al. Adjustable parameters and the effectiveness of adjunct robot-assisted gait training in individuals with chronic stroke
WO2006102933A8 (en) Preparation of autologous haematopoietic stem cells, the methods of production, cyropreservation and use for therapy of traumatic diseases of the central nervous system
DE3914869C1 (enExample)
CN103083362B (zh) 一种多用途功能水及其制备方法
HU9401185D0 (en) Method and composition for determining the immunological activity of bioactive substances
Zhang et al. Electroacupuncture promotes nerve regeneration and functional recovery in rats with spinal cord contusion through the coordinate interaction of CD4 and BDNF
Di Sarno et al. Intranasal Human-Recombinant Nerve Growth Factor Enhances Motor and Cognitive Function Recovery in a Child with Severe Traumatic Brain Injury
WO2001064240A3 (en) Methods for promoting production of myelin by schwann cells
JPS6041615A (ja) コロニ−形成刺激因子の製造方法
ATE239492T1 (de) Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen
CN104560925A (zh) 一种从人凝血因子ⅸ层析废液中激活制备人凝血酶的方法
HRP20140247T1 (hr) Cjepivo protiv raka
Jeon et al. Investigating effects of negative emotional states on the korean elderly's osteoarthritis prevalence
Le et al. Selenium in Biological Fluids in the Bodies of Patients with Associated Trauma
Vasiuk et al. Selenium in Biological Fluids in the Bodies of Patients with Associated Trauma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties